跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
heart-derived stem cell therapy
首页
药物
heart-derived stem cell therapy
heart-derived stem cell therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (BMPS) and/or blood-derived circulating precursor cells (BDPS)
US 7919315 B2
申请人: T2CURE GMBH
优先权: 2003
CN
US
3 件公开
Methods for improving cell therapy and tissue regeneration in patients with cardiovascular and neurological diseases by means of shockwaves
US 2006246044 A1
申请人: DORNIER MEDTECH SYSTEM GMBH
优先权: 2005
US
3 件公开
POPULATION OF ADULT STEM CELLS DERIVED FROM CARDIAC ADIPOSE TISSUE AND USE THEREOF IN CARDIAC REGENERATION
US 2010304477 A1
申请人: GENETRIX S L
优先权: 2007
CN
US
2 件公开
Intracoronary injection of a mixture of autologous bone marrow derived mononuclear cells and autologous bone marrow derived mesenchymal stem cells for utilization and rescue of infarcted myocardium
US 2008038229 A1
申请人: MINGUELL JOSE J
优先权: 2006
US
2 件公开
Preparation for treating heart disease used in cell therapy
US 8414924 B2
申请人: OH HIDEMASA
优先权: 2007
US
2 件公开
Methods of using G-CSF mobilized C-Kit+ cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy
US 2005186182 A1
申请人: DEISHER THERESA
优先权: 2004
US
Intracoronary, intracardiac, or intravenous infusion of a mixture of autologous bone marrow derived mononuclear cells and autologous bone marrow derived mesenchymal stem cells for utilization and rescue of infarcted myocardium
US 2009035286 A1
申请人: MINGUELL JOSE J
优先权: 2008
US
Cardiac Conduction System (CCS) Progenitor Cells and Uses Thereof
US 2010285580 A1
申请人: EVANS SYLVIA
优先权: 2008
US
Preparation method and application of pluripotent stem cell derived endothelial cell exosome
CN 115466715 A
申请人: SHANGHAI EAST HOSPITAL TONGJI UNIV AFFILIATED EAST HOSPITAL
优先权: 2022
CN
药物
反馈